🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Elena Fountzilas

European University Cyprus

ORCID: 0000-0002-4884-2544

Also affiliated with St. Luke's Hospital, Hellenic Cooperative Oncology Group, St Luke's Hospital, G. Papanikolaou General Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.477Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Dataset of phase I and II immunotherapy clinical trials used for a meta-analysis to assess the role of biomarkers in treatment outcomes in diverse cancers

Data in Brief(2023)10.1016/j.dib.2023.109698
Top 40%
0.477DataRank
Top 40%4 citations

Henry Hiep Vo, Peter Müeller, Razelle Kurzrock, Apostolia M. Tsimberidou, Elena Fountzilas

Papers

Driven by 8 papers — median percentile 60. Top paper: “Review of precision cancer medicine: Evolution of the treatment paradigm”.

Review of precision cancer medicine: Evolution of the treatment paradigm

Cancer Treatment Reviews(2020)10.1016/j.ctrv.2020.102019
N/A
0.987DataRank · unranked
720 citations

Elena Fountzilas, Mina Nikanjam, Razelle Kurzrock, Apostolia M. Tsimberidou

Dataset of phase I and II immunotherapy clinical trials used for a meta-analysis to assess the role of biomarkers in treatment outcomes in diverse cancers

Data in Brief(2023)10.1016/j.dib.2023.109698
Top 40%
0.477DataRank
Top 40%4 citations

Henry Hiep Vo, Peter Müeller, Razelle Kurzrock, Apostolia M. Tsimberidou, Elena Fountzilas

Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab067
N/A
0DataRank · unranked
48 citations

Razelle Kurzrock, Henry Hiep Vo, Apostolia M. Tsimberidou, Elena Fountzilas

Biomarkers and Outcomes in Diverse Cancers: Meta-Analysis of Early Phase Immuno-Oncology Trials

Research Square(2022)10.21203/rs.3.rs-2386222/v1
N/A
0DataRank · unranked
0 citations

Henry Hiep Vo, Peter Müeller, Razelle Kurzrock, Apostolia M. Tsimberidou, Elena Fountzilas

Correlation between biomarkers and treatment outcomes in diverse cancers: a systematic review and meta-analysis of phase I and II immunotherapy clinical trials

European Journal of Cancer(2023)10.1016/j.ejca.2023.05.015
N/A
0DataRank · unranked
19 citations

Henry Hiep Vo, Peter Müeller, Razelle Kurzrock, Apostolia M. Tsimberidou, Elena Fountzilas

Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design

Cancer Treatment Reviews(2024)10.1016/j.ctrv.2024.102703
N/A
0DataRank · unranked
22 citations

Apostolia M. Tsimberidou, Henry Hiep Vo, Razelle Kurzrock, Elena Fountzilas

Convergence of evolving artificial intelligence and machine learning techniques in precision oncology

npj Digital Medicine(2025)10.1038/s41746-025-01471-y
N/A
0DataRank · unranked
164 citations

Tillman Pearce, Mehmet A. Baysal, Abhijit Chakraborty, Apostolia M. Tsimberidou, Elena Fountzilas

Transcriptomics and solid tumors: The next frontier in precision cancer medicine

Seminars in Cancer Biology(2020)10.1016/j.semcancer.2020.09.007
N/A
0DataRank · unranked
107 citations

Elena Fountzilas, Leonidas Bleris, Razelle Kurzrock, Apostolia M. Tsimberidou